| Literature DB >> 34110786 |
Marita Meurer1,2, Deborah A O'Neil3, Emma Lovie3, Laura Simpson3, Marcelo D T Torres4,5,6, Cesar de la Fuente-Nunez4,5,6, Alfredo M Angeles-Boza7,8, Christin Kleinsorgen9, Derry K Mercer3, Maren von Köckritz-Blickwede1,2.
Abstract
The need for optimized as well as standardized test systems of novel antimicrobial peptides (AMPs) was discussed by experts in the field at the International Meeting on Antimicrobial Peptides (IMAP) 2017 and the 2019 Gordon Research Conference (GRC) on Antimicrobial Peptides, and a survey related to this topic was circulated to participants to collate opinions. The survey included questions ranging from the relevance of susceptibility testing for understanding the mode of action of AMPs, to the importance of optimization and a degree of standardization of test methods and their clinical relevance. Based on the survey results, suggestions for future improvements in the research field are made.Entities:
Mesh：
Substances：
Year: 2021 PMID： 34110786 PMCID： PMC8764967 DOI： 10.1021/acsinfecdis.1c00210
Source DB: PubMed Journal: ACS Infect Dis ISSN： 2373-8227 Impact factor: 5.084